Yet another report, adding detail, and background, in-country:
. . . .A chemist who spoke on condition of anonymity said that patients at his hospital can save billions of dong (hundreds of thousands of dollars) a month if drug prices are not marked up by commissions to physicians.
"It explains why health expenditures have gone up so unreasonably," he said. . . .
MSD Pharmaceuticals has petitioned the Ministry for an extended deadline to submit its own explanations. . . .
So, New Merck will need a few extra weeks to figure out what legacy Schering-Plough was doing in Vietnam, under Ex-CEO Fred Hassan and his deputy, Carrie Cox. Huge surprise. Or not.